GetTopicDetailResponse(id=83ef1258e086, topicName=他雷替尼, introduction=, content=非小細(xì)胞肺癌 ROS1 他雷替尼, image=null, comments=0, allHits=252, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue Apr 08 22:34:21 CST 2025, time=2025-04-08, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=503302, tagList=[TagDto(tagId=503302, tagName=他雷替尼)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2259670, encodeId=d0ea22596e08b, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細(xì)胞肺癌#</a> <a href='/topic/show?id=0717156309a' target=_blank style='color:#2F92EE;'>#ROS1#</a> <a href='/topic/show?id=83ef1258e086' target=_blank style='color:#2F92EE;'>#他雷替尼#</a>, objectTitle=JCO | TRUST研究結(jié)果：他雷替尼在ROS1陽(yáng)性NSCLC患者中的高緩解率與持久療效?, objectType=article, longId=870967, objectId=23938e096722, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250121/1737454189523_8538692.png, objectUrl=/article/show_article.do?id=23938e096722, replyNumber=0, likeNumber=49, createdTime=2025-04-08, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=23938e096722, moduleTitle=JCO | TRUST研究結(jié)果：他雷替尼在ROS1陽(yáng)性NSCLC患者中的高緩解率與持久療效?, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=23938e096722)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-04-08發(fā)表于陜西省
